Erythropoietin is a glycoprotein hormone produced by the kidney. Erythropoietin is a hormone that controls the production of erythrocytic progenitors. Since 1989, erythropoietin (EPO) has been used to treat anemia-related diseases. The formulation of the EPO product was altered in 2004. The occurrence of creutzfeldt-jakob disease (CJD) led to the replacement of the stabilizer, human serum a…
Background – PT. Etana Biotechnologies Indonesia is planning to produce recombinant human erythropoietin (rhEPO). After the production process, the residue determination shall be conducted to check the presence of residue preventing cross-contamination between batches. The study will focus on EPO residue determination where the swab method will be optimized to determine the residual amount of…